In the absence of effective interventions to prevent preterm births, improved survival of
infants who are born at the biological limits of viability has relied on advances in perinatal …

Bronchopulmonary dysplasia (BPD) is a chronic lung disease of primarily premature infants
that results from an imbalance between lung injury and repair in the developing lung. BPD is …

Importance The benefits of surfactant administration via a thin catheter (minimally invasive
surfactant therapy [MIST]) in preterm infants with respiratory distress syndrome are …

Although bronchopulmonary dysplasia (BPD) is the most frequent adverse outcome for
infants born at< 30 weeks gestational age, there remain major gaps in understanding the …

Bronchopulmonary dysplasia (BPD) is one of the few diseases in neonatal medicine that
has continued to evolve since its first description about 50 years ago. Over these years …

STING-associated vasculopathy with onset in infancy (SAVI) is a type I interferonopathy
caused by gain-of-function mutations in STING1 encoding stimulator of interferon genes …

The objective of lung development is to generate an organ of gas exchange that provides
both a thin gas diffusion barrier and a large gas diffusion surface area, which concomitantly …

The aryl hydrocarbon receptor (AHR) is a cytoplasmic transcription factor that is well-known
for regulating xenobiotic metabolism. Studies in knockout and transgenic mice indicate that …

Bronchopulmonary dysplasia (BPD) is the most common complication of preterm birth, with
appreciable morbidity and mortality in a neonatal intensive care setting. Much interest has …

Yearly more than 15 million babies are born premature (< 37 weeks gestational age),
accounting for more than 1 in 10 births worldwide. Lung injury caused by maternal …